Publicacións en colaboración con investigadores/as de Universidad de Sevilla (17)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

  3. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy

    Hepatology (Baltimore, Md.), Vol. 80, Núm. 4, pp. 791-806

  4. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

2023

  1. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  2. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

    Gut, Vol. 71, Núm. 10, pp. 2138-2140

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

2019

  1. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  2. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

    PLoS ONE, Vol. 14, Núm. 11

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

2014

  1. Aproximación metodológica al diseño de un sistema de teleasistencia para pacientes en prediálisis y diálisis peritoneal

    Nefrologia, Vol. 34, Núm. 2, pp. 149-157

2004

  1. Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: Effects of estrogen treatment

    European Journal of Internal Medicine, Vol. 15, Núm. 4, pp. 231-237

2003

  1. Bone mass, bone turnover, vitamin D, and estrogen receptor gene polymorphisms in male to female transsexuals: Effects of estrogenic treatment on bone metabolism of the male

    Journal of Clinical Densitometry, Vol. 6, Núm. 3, pp. 297-304

  2. Efecto de la administración crónica de estrógenos en varones transexuales sobre el metabolismo mineral óseo. Influencia del polimorfismo del receptor de la vitamina D

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 12, Núm. 6, pp. 109-116